Gladstone Home GICD Home Blank GIVI Home GIND Home Blank
 
 
Supporting Gladstone
Advisory Council Update
title
A full meeting of the Advisory Council took place at Gladstone on Thursday, November 1, under the continued leadership of Chair Bill Price.

Advisory Council
Trustee Andy Garb presents outgoing chair Moe Cevallos with an engraved gavel to commemorate his service to the Council

The evening began at 5:00 p.m. with meetings of three of the individual committees: Strategic Planning, Intellectual Property, and Community Relations. A reception in the library followed and then the Council moved to the Siegel-Reed Board Room for formal presentations.

Reports from the Trustees, the President, and the Chair focused on fundraising and the administrative costs of running a research institute. Trustee Andy Garb also presented Moe Cevallos, previous Chair of the Council, with an engraved gavel to commemorate his support and leadership at Gladstone.

  Committee reports followed led by Moe Cevallos and Sue Siegel, Chair of the Community Relations Committee. Ms. Siegel highlighted several programs under way to promote public awareness of the Gladstone name and to increase philanthropic support.

Each meeting includes a scientific presentation. At this meeting, Melanie Ott (GIVI) discussed the hepatitis C virus (HCV) and its unexpected connection with fat. Worldwide, it is estimated that 170 million people are infected with HCV. Her laboratory studies the effect of certain proteins on HCV, and it is hoped that understanding the biology of these proteins will promote the development of novel therapeutic strategies against the disease.

The next meeting of the Advisory Council will take place on April 1, 2008.

Advisory Council
Sue Desmond-Hellmann and GICD investigator Izzy Charo

 
title
Charlyn Belluzzo It is with great pleasure that we announce the addition of Charlyn Belluzzo, PhD, MBA, to the Gladstone Advisory Council. Charlyn's nomination was suggested by Council member Pat Christen who describes Charlyn as a smart, high-energy, generous-spirited woman.

Charlyn's extensive and varied background and international contacts in the research and business worlds certainly make her a valuable member of an already impressive group. Charlyn has made significant contributions in the areas of global health, research, and adult education and is a frequent speaker and panelist at international forums and conferences. She applies her expertise in research, evaluation, and education in numerous international settings.

  She is director of the Rwanda Community Development Alliance, facilitating programs spanning healthcare, education, agriculture, microfinance, and security.

Charlyn is also a faculty member of the Medical Knowledge Institute. Based in the Netherlands, the Institute provides programs that promote and improve the quality of healthcare as a human right in the developing world, with a particular focus on the issues of cancer care and HIV/AIDS.

Charlyn earned graduate degrees and received post-graduate training from LaSalle University, University of Colorado School of Business, Georgetown University School of Medicine, and Tulane University School of Public Health and Tropical Medicine. She is a member of the United Nations Business Council, University of California Center for Global Health, American College of Healthcare Executives, Association of Clinical Research Professionals, and American College of Nutrition.

We welcome Charlyn Belluzzo and look forward to her advice and counsel.

—Shaundra Bason, Director of Development

 
The Gladstone Advisory Council

M. Kathleen Behrens Wilsey, PhD
General Partner
RS & Co. Venture Partners IV
RS Investments

Charlyn Belluzzo, MBA, PhD
Managing Partner
Corso Partners, LLC

Edwin L. Berkowitz
General Partner
The Halo Funds

Ted B. Breck
Principal
TPG-Axon Capital

Mauricio F. Cevallos
Executive Vice President (retired)
Loomis, Sayles & Company
Chief Executive Officer and Founding Partner
Lattice Capital Management

Pat Christen
President
HopeLab

Fred Craves, PhD
Founder and Managing Director
Bay City Capital

Susan D. Desmond-Hellmann, MD, MPH
President, Product Development
Genentech, Inc.

  Robin Richards Donohoe
General Partner
Draper Richards Venture Funds

Frederick J. Dorey
Special Counsel
Cooley Godward Kronish LLP

Alan D. Frazier
Founder and Managing Partner
Frazier Healthcare Ventures

David V. Goeddel, PhD
Managing Partner
The Column Group

David L. Gollaher, PhD
President and
Chief Executive Officer
California Healthcare Institute

William R. Hambrecht
Founder, Chairman, and
Co-Chief Executive Officer
WR Hambrecht + Co

Mary Huss
Publisher
San Francisco Business Times

Julius R. Krevans, MD
Chancellor Emeritus
University of California, San Francisco

  Joel S. Marcus
Chief Executive Officer,
Founder, and Director
Alexandria Real Estate Equities, Inc.

Donald G. Payan, MD
Executive Vice President and
Chief Scientific Officer
Rigel, Inc.

H. Daniel Perez, MD
Venture Partner
Bay City Capital

J. Misha Petkevich, DPhil
Partner
BladeRock Capital, LLC

David R. Phillips, PhD
Senior Vice President, Biology
Portola Pharmaceuticals, Inc.

Lisa R. Pieper, MD, MBA
Life Sciences Practice
Spencer Stuart

William S. Price III (Chair)
Founding Partner
TPG Capital, LP

Derek C. Schrier
Managing Member
Farallon Capital Management, LLC

  Stephen A. Sherwin, MD
Chairman and Chief Executive Officer
Cell Genesys, Inc.

Susan E. Siegel
Partner
Mohr Davidow Ventures

Nicholas J. Simon
Managing Director
Clarus Ventures, LLC

Bruce W. Spaulding
Senior Vice Chancellor
University Advancement
and Planning
University of California,
San Francisco

Trevor Traina
Chairman
SchemaLogic, Inc.

Lisa Walsh
Partner and Director
Bain & Company

Brayton Wilbur, Jr. (dec.)
Chairman
Wilbur-Ellis Company

W. Blake Winchell
Managing General Partner
Fremont Ventures

William H. Younger, Jr.
Managing Director
Sutter Hill Ventures

TOP


Gladstone Home | Cardiovascular Disease | Virology and Immunology | Neurological Disease | Administration | UCSF